Full text
Earnings transcript
Read the complete earnings call transcript.
TPVG
TriplePoint Venture Growth BDC Corp.
$5.47
0.04
(0.74%)
| Exchange: | NYSE |
| Market Cap: | 222.076M |
| Shares Outstanding: | 9.87M |
Delayed data
About The Company
| Sector: | Financial Services | |||||
| Industry: | Asset Management | |||||
| CEO: | James Peter Labe | |||||
| Full Time Employees: | ||||||
| Address: |
| |||||
| Website: | https://www.tpvg.com |
TriplePoint Venture Growth BDC Corp. (TPVG) functions as a business development company, primarily concentrating its investments on growth-stage enterprises backed by venture capital. The firm’s core offering involves providing debt financing solutions to companies within the venture growth ecosystem. These solutions encompass a diverse range of products, such as growth capital loans, customized and secured credit facilities, equipment financing, and revolving lines of credit. Additionally, TPVG engages in direct equity investments. Its investment strategy targets companies operating in key sectors, including e-commerce, entertainment, technology, and life sciences. Within the technology sphere, the areas of specific interest are broad, covering cybersecurity, wireless communication equipment, network systems and software, business application software, conferencing solutions, big data analytics, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, various software categories (including Software-as-a-Service), and other related technological subsectors. For life sciences, TPVG focuses on biotechnology, biofuels/biomass, diagnostic testing and bioinformatics, drug delivery systems, drug discovery, healthcare information systems, healthcare services, medical/surgical/therapeutic devices, pharmaceuticals, and other related fields. The size of TPVG’s investments varies based on the type of financing: growth capital loans typically range from $5 million to $50 million, equipment financings are between $5 million and $25 million, and revolving loans generally fall between $1 million and $25 million. Direct equity investments, conversely, are usually from $0.1 million to $5 million, and are structured to not exceed 5% of the portfolio company’s total equity. The debt financing instruments are commonly structured as lines of credit, and the company also employs warrants and secured loans in its funding approach. TPVG aims to achieve targeted returns of 10% to 18%. A distinctive aspect of its investment policy is that it does not seek board representation in the companies it finances.
Click to read more…
Revenue Segmentation
EPS
Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.
Earnings Call
AI summary
Key takeaways
Short, structured highlights from the call so you can focus on what matters.
Log in to continue
Log in to read the full transcript and AI-generated earnings summaries.
Login — it's freeIncome Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 5,970 | 71,187 | 97,209 |
| Gross Profit | -27,069 | 45,532 | 81,180 |
| EBITDA | -39,821 | 32,046 | 75,727 |
| Operating Income | -39,821 | 32,046 | 75,727 |
| Net Income | -39,821 | 32,046 | 49,207 |
(* All numbers are in thousands)
Balance Sheet
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total Assets | 978,825 | 763,040 | 839,649 |
| Total Liabilities | 632,519 | 417,353 | 486,028 |
| Total Stockholders Equity | 346,306 | 345,687 | 353,621 |
| Total Debt | 607,896 | 398,827 | 469,080 |
| Cash and Cash Equivalents | 153,328 | 45,899 | 20,364 |
(* All numbers are in thousands)
Cash Flow Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating Cash Flow | 106,148 | 152,921 | -57,033 |
| Capital Expenditure | 0 | 0 | 0 |
| Free Cash Flow | 106,148 | 152,921 | -57,033 |
| Net Income | -39,821 | 0 | 0 |
| Net Change in Cash | 112,322 | -92,855 | -31,360 |
(* All numbers are in thousands)
Analyst Estimates
| Fiscal Year | 2028 | Full Access | Full Access | Full Access | Full Access |
|---|---|---|---|---|---|
| Estimated Revenue (Low) | 88,370.511 | Full Access | Full Access | Full Access | Full Access |
| Estimated Revenue (High) | 92,579.792 | Full Access | Full Access | Full Access | Full Access |
| Estimated Revenue (Avg) | 90,392 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (Low) | -200.896 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (High) | -191.762 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (Avg) | -196.148 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (Low) | 26,982.504 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (High) | 28,664.832 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (Avg) | 28,172 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (Low) | 39,823.382 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (High) | 41,720.257 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (Avg) | 40,734.348 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (Avg) | 0.690 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (High) | 0.710 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (Low) | 0.670 | Full Access | Full Access | Full Access | Full Access |
| Number of Analysts (Estimated Revenue) | 1 | Full Access | Full Access | Full Access | Full Access |
| Number of Analysts (Estimated EPS) | 1 | Full Access | Full Access | Full Access | Full Access |
Log in to continue
Log in and subscribe to Full Access to see up to 5 years of analyst estimates.
Login — it's free(* All numbers are in thousands)
Current Key Metrics
Log in to continue
Log in to see all key valuation metrics and ratios for this symbol.
Login — it's freeForward P/E Ratios
Log in to continue
Log in with Full Access for forward P/E high/low estimates and the full multi-year table.
Login — it's freeSWOT Analysis
At what price to buy it? -
Intrinsic Value Calculator
Based on current fundamentals and analyst forecasts, MARKETSnap estimates TPVG intrinsic value between $24.70 – $57.55 per share. This depends on revenue growth, margins, and discount rate.
This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.
[intrinsic_calculator]
Common questions about TPVG valuation
Is TriplePoint Venture Growth BDC Corp. (TPVG) overvalued or undervalued right now?
MARKETSnap estimates intrinsic value for TriplePoint Venture Growth BDC Corp. (TPVG) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.
Is TPVG a buy, hold, or sell for long-term investors?
MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether TPVG trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.
What is TPVG’s P/E ratio?
You can see TPVG’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.
How is intrinsic value calculated for TPVG?
MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.
Is TPVG a good long-term investment?
Whether TPVG fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.
TPVG
1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.
Daily snapshot
0.74
Trading Metrics:
| Open: | 5.43 | Previous Close: | 5.43 | |
| Day Low: | 5.42 | Day High: | 5.53 | |
| Year Low: | 4.48 | Year High: | 7.53 | |
| Price Avg 50: | 5.41 | Price Avg 200: | 5.83 | |
| Volume: | 120283 | Average Volume: | 442663 |
Log in to continue
Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.
Login — it's free
